Shevchuk Y M, Conly J M
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
Rev Infect Dis. 1990 Nov-Dec;12(6):1109-26.
Many antimicrobial agents have been associated with hypoprothrombinemia. The precise mechanisms are unknown, but alteration in vitamin K status or utilization is involved. The two postulated mechanisms implicate either direct inhibition of biosynthesis of the vitamin K-dependent clotting factors by the N-methylthiotetrazole (NMTT) moiety found in certain antimicrobial agents or eradication of vitamin K-producing intestinal microflora in patients with reduced oral intake of vitamin K. An English-language review of all prospective studies reported between 1966 and 1988 in which serial prothrombin times were monitored in adult patients revealed that the incidence of hypoprothrombinemia varied from 3.7% to 64% with NMTT-containing regimens and from 0% to 24% with non-NMTT-containing regimens. Detailed evaluation of these and other studies suggests that certain risk factors, including malnutrition, hepatic and renal dysfunction, older age, and severity of illness, may be the major determinants of hypoprothrombinemia. The hypothesis that the NMTT side chain is primarily responsible for hypoprothrombinemia may not be justified. We conclude that patients at high risk for coagulopathy should be carefully monitored and that serious consideration should be given to the use of prophylactic vitamin K in such cases.
许多抗菌药物都与低凝血酶原血症有关。确切机制尚不清楚,但与维生素K状态或利用的改变有关。两种推测的机制要么是某些抗菌药物中发现的N-甲基硫代四唑(NMTT)部分直接抑制维生素K依赖性凝血因子的生物合成,要么是在维生素K口服摄入量减少的患者中根除产生维生素K的肠道微生物群。对1966年至1988年间报道的所有前瞻性研究进行的英文综述显示,在成年患者中监测连续凝血酶原时间,含NMTT方案的低凝血酶原血症发生率为3.7%至64%,不含NMTT方案的发生率为0%至24%。对这些研究和其他研究的详细评估表明,某些危险因素,包括营养不良、肝肾功能不全、老年和疾病严重程度,可能是低凝血酶原血症的主要决定因素。NMTT侧链是低凝血酶原血症主要原因的假设可能不合理。我们得出结论,应仔细监测有凝血病高风险的患者,在这种情况下应认真考虑使用预防性维生素K。